Seboreik Dermatit ve Telogen Effluvium Birlikteliği olan Hastalarda D Vitamini Düzeyi

Amaç: Yapılan çalışmalarda vitamin D düzeyi ile birçok kronik hastalık ve deri hastalığı arasında ilişki gösterilmiştir. Bu çalışmada sık görülen dermatolojik hastalıklar olan seboreik dermatit (SD) ve telogen effluvium (TE) ile D vitamin düzeyi arasındaki ilişkinin araştırılması amaçlandı. Gereç ve Yöntem: Öykü ve dermatolojik muayene neticesinde SD ve TE tanısı konulan hastalar çalışmada hasta grubuna, sadece TE tanısı konulan hastalar ise çalışmada kontrol grubuna dahil edildi. Tüm hastaların serum 25-OH D vitamin düzeyleri ölçüldü. Bulgular: Çalışmaya 69 hasta (SD ve akut TE; n =42 ve SD ve kronik TE; n =27) ve 80 kontrol (akut TE; n =69 ve kronik TE; n =11) grubunda olmak üzere toplam 149 gönüllü katıldı. Serum 25-OH D vitamin düzeyi akut TE tanılı hastalarda 14.59±4.68 ng/mL, kronik TE tanılı hastalarda 16.86±7.31, SD ve akut TE birlikteliği olan hastalarda 15.33±7.97ng/mL, SD ve kronik TE birlikteliği olan hastalarda 17.73±5.17ng/mL saptandı. Serum 25-OH D vitamini düzeyi SD ve kronik TE birlikteliği olan hastalarda SD ve akut TE birlikteliği olan hastalara göre anlamlı olarak daha yüksek saptandı (p

Vitamin D Levels in Patients with Seborrheic Dermatitis and Telogen Effluvium

Objective: Studies have shown the relationship between vitamin D levels and many chronic diseases and skin diseases. The aim of this study was to investigate the relationship between vitamin D levels and commonly seen dermatological diseases like seborrheic dermatitis (SD) and telogen effluvium (TE). Material and Method: As a result of history and dermatological examination, patients diagnosed with SD and TE were included in the patient group, and patients diagnosed only with TE were included in control group. Serum 25-OH vitamin D levels were measured in all patients. Results: A total of 149 volunteers, 69 patients (SD and acute TE; n =42 and SD and chronic TE; n =27) and 80 controls (acute TE; n =69 and chronic TE; n =11) participated in the study. Serum 25-OH vitamin D level was 14.59±4.68 ng/mL in patients with acute TE, 16.86±7.31 ng in patients with chronic TE, 15.33±7.97 ng/mL in patients with SD and acute TE, 17.73±5.17 ng/mL in patients with SD and chronic TE. Serum 25-OH vitamin D level was significantly higher in patients with SD and chronic TE compared to patients with SD and acute TE (p

PDF

___

1. Kechichian E, Ezzedine K. Vitamin D and the Skin: An Update for Dermatologists. 2. Am J Clin Dermatol 2018; 19: 223-35.
3. Fidan F, Alkan BM, Tosun A. Çağın Pandemisi: D vitamini eksikliği ve yetersizliği. Türk Osteoporoz Dergisi 2014; 20: 71-4.
4. Wadhwa B, Relhan V, Goel K, Kochhar AM, Garg VK. Vitamin D and skin diseases: A review. Indian J Dermatol Venereol Leprol 2015; 81: 344- 55.
5. Amrein K, Scherkl M, Hoffmann M. Vitamin D deficiency 2.0: an update on the current status world wide. Eur J Clin Nutr 2020; 74: 1498-513.
6. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
7. Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI. Vitamin D and the Pathophysiology of Inflammatory skin diseases. Skin Pharmacol Physiol 2018; 31: 74-86.
8. Bikle DD, Gee E, Pillai S. Regulation of keratinocytegrowth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol 1993; 101: 713-8.
9. Unal M, Gonulalan G. Serum vitamin D level is related to disease severity in pediatric alopecia areata. J Cosmet Dermatol 2018; 17: 101-4.
10. Wu PW, Rhew EY, Dyer AR et al. 25- Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 1387-95.
11. 10.Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus2012; 21: 36-42.
12. Amital H, Szekanecz Z, Szücs G et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 1155-7.
13. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician 2006; 74: 125-30.
14. Wat H, Dytoc M. Off-labeluses of topical vitamin D in dermatology: a systematic review. J Cutan Med Surg 2014; 18: 91-108.
15. Berth-Jones J, Adnitt PI. Topical calcipotriol is not effective in facial seborrhoeic dermatitis. J Dermatolog Treat 2001; 12: 179.
16. Rasheed H, Mahgoub D, Hegazy R et al. Serum ferritin and vitamin D in female hair loss: do they play a role? Skin Pharmacol Physiol 2013; 26: 101-7.
17. Nayak K, Garg A, Mithra P, Manjrekar P. Serum vitamin D3 levels and diffuse hair fall among the student population in south ındia: A case-control study. Int J Trichol 2016; 8: 160-4.
18. Gürel G, Karadöl M, Çölgeçen E. Telogen effluviyumda ferritin ve D vitamini seviyelerinin rolü. Turkiye Klinikleri J Dermatol 2017; 27: 113-6.
19. Karadag AS, Ertugrul DT, Tutal E, Akin KO. The role of anemia and vitamin D levels in acute and chronic telogen effluvium. Turkish J Med Sci 2011; 41: 827-33.
20. Cheung EJ, Sink JR, English Iii JC. Vitamin and mineral deficiencies in patients with telogeneffluvium: A retrospective cross-sectionalstudy. J Drugs Dermatol 2016; 15: 1235-20. 20. Gerkowicz A, Chyl-Surdacka K, Krasowska D, Chodorowska G. The Role of vitamin D in Non-Scarring Alopecia. Int J MolSci 2017; 18: 2653.